Antipsychotic use in dementia: a systematic review of benefits and risks from meta-analyses
Tampi RR, Tampi DJ, Balachandran S, Srinivasan S. Antipsychotic use in dementia: a systematic review of benefits and risks from meta-analyses. Therapeutic Advances In Chronic Disease 2016, 7: 229-245. PMID: 27583123, PMCID: PMC4994396, DOI: 10.1177/2040622316658463.Peer-Reviewed Original ResearchUse of antipsychoticsLewy body dementiaSystematic reviewAlzheimer's diseaseAdverse effectsDiscontinuation of antipsychoticsNonpharmacological management strategiesAdverse effect profileEfficacy of antipsychoticsEffect profileAntipsychotic useModest efficacyCochrane CollaborationAntipsychoticsSevere symptomsFollowing keywordsDementiaLiterature searchFinal analysisAdditional studiesOfficial English translationsPatientsDiseaseEnglish-language journalsBibliographic databasesThe Treatment of Behavioral and Psychological Symptoms of Dementia: Weighing Benefits and Risks.
Zdanys KF, Carvalho AF, Tampi RR, Steffens DC. The Treatment of Behavioral and Psychological Symptoms of Dementia: Weighing Benefits and Risks. Current Alzheimer Research 2016, 13: 1124-33. PMID: 27160166, DOI: 10.2174/1567205013666160510121633.Peer-Reviewed Original ResearchConceptsPsychological symptomsAssessment of BPSDManagement of BPSDPharmacologic treatment strategiesTreatment of BehavioralSignificant adverse effectsAvailable medicationsTreatment strategiesCurrent evidencePharmacological approachesWeighing benefitsBPSDDementiaAged populationAdverse effectsMedicationsPatientsSymptomsAvailable literatureRiskCaregivers